Novo Nordisk sees 65% obesity drug sales growth, forecasts $8.14–$9.59B FY25 free cash flow. Click here to read an analysis ...

Some people are discovering that being thinner can sometimes mean looking older. Local cosmetic surgeons weigh-in with ...

Eight weeks. That’s how long it takes, on average, for the pounds to begin creeping back after someone stops taking the world ...

Ozempic and Zepbound are both prescription injections that are part of the GLP-1 drug class. They have different active ...

Whether the headlines cite Ozempic or obesity, Western media remains fixated on weight. But in East Asia, the conversation ...